The largest database of trusted experimental protocols

Cobas ampliprep cobas taqman hiv test

Manufactured by Roche
Sourced in Germany

The COBAS AmpliPrep/COBAS TaqMan HIV test is a laboratory instrument used for the quantitative detection of HIV-1 RNA in human plasma. It is designed to measure the viral load of HIV-1 in infected individuals.

Automatically generated - may contain errors

4 protocols using cobas ampliprep cobas taqman hiv test

1

Quantifying Viral Loads with Cobas TaqMan

Check if the same lab product or an alternative is used in the 5 most similar protocols
The ID-NAT yield donations were tested further with the discriminatory COBAS AmpliPrep/COBAS TaqMan HBV test, COBAS AmpliPrep/COBAS TaqMan HCV test, and COBAS AmpliPrep/COBAS TaqMan HIV test (Roche Molecular Systems) on a Cobas TaqMan analyzer (Roche Diagnostics Company, Shanghai, China). The manufacturer states that the lower limit of detection for the HBV DNA assay is 20 IU/mL. Hepatitis B virus DNA of follow-up samples was tested for viral load by the same method.
+ Open protocol
+ Expand
2

Quantitative HIV-1 RNA Measurement

Check if the same lab product or an alternative is used in the 5 most similar protocols
According to the manufacturer's instructions, the levels of HIV-1 RNA were measured in fresh plasma and CSF samples using quantitative PCR (COBAS AmpliPrep/COBAS TaqMan HIV test; Roche Molecular Systems, Switzerland), with a lower limit of quantification of 20 RNA copies/mL.
+ Open protocol
+ Expand
3

HIV Viral Load Monitoring Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
HIV-1 VL was quantified by either Abbott m2000sp/Abbott m2000rt platform (Wiesbaden, Germany), Cobas TaqMan/Cobas Ampliprep HIV-test (Roche Molecular Systems, Branchburg, NJ, USA) or Aptima HIV-1 Quant assay on Panther Systems (Hologic inc., San Diego, CA, USA) at BHHRL or district-based laboratories. VF was defined as two consecutive VL greater than 400 copies/mL and virologic suppression as a viral load < 400 copies/mL as per national ART guidelines. Because of the various VL detection platforms used and changes in the national VL reporting guidelines, some of the VL data was reported as <400, <50, <40 and <25 copies/mL.
+ Open protocol
+ Expand
4

HIV Viral Load Testing Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
HIV viral load testing from plasma specimens was performed using the Abbott m2000sp/Abbott m2000rt platform (Wiesbaden, Germany), Cobas TaqMan/Cobas Ampliprep HIV-test (Roche Molecular Systems, Branchburg, NJ, United States) at Botswana Harvard Health Partnership (BHP) according to the manufacturer’s instructions. At the time of enrolment VF was defined as two consecutive VLs greater than 400 copies/mL and virologic suppression as a viral load <400 copies/mL as per national ART guidelines. The lower limit of detection (LOD) in plasma is 40 copies/mL for this VL detection platform (See Figure 2).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!